The specific genomic region where this non-coding RNA is located often gets damaged in breast cancer patients — this control is removed and the cancer cells spread.»
When Ago1 binds to small interfering RNAs (siRNAs) that originate from
a specific genomic region, it helps shut down the activity of that genomic region.